Systematic Review
Published on 29 Dec 2022
Efficacy and safety of CD22-specific and CD19/CD22-bispecific CAR-T cell therapy in patients with hematologic malignancies: A systematic review and meta-analysis
in Hematologic Malignancies
- 4,226 views
- 8 citations












